Multi4 Medical Receives CE Mark – Moves Bladder Cancer Treatment from Operating Room to Outpatient Setting

The Swedish MedTech company Multi4 Medical has received CE mark approval for the Multi4 System – a groundbreaking all-in-one technology that enables bladder cancer treatment during the same outpatient visit when cancer is detected, without operating room, anesthesia, or hospitalization.   The CE mark means the Multi4 System can now be deployed throughout Europe and marks a paradigm shift in urologic cancer care. With the world's first all-in-one instrument, urologists can perform the entire treatment endoscopically on an awake patient – what typically requires a scheduled operation